Imaging (Fig. 5a) and biodistribution studies (Fig. 5b) at 48 h p.i. revealed high uptake and retention in the tumour, which was twofold greater for EGFR-targeted AuNPs (197% ID/g) than non-targeted AuNPs (99% ID/g). The gene discussed is EGFR; the disease is neoplasm.